Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GENE

Genetic Technologies (GENE)

Genetic Technologies Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GENE
DateTimeSourceHeadlineSymbolCompany
05/28/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
05/23/20248:00AMGlobeNewswire Inc.GeneType and Humanise Health host “Know Your Risk” EventNASDAQ:GENEGenetic Technologies Ltd
05/06/20248:00AMGlobeNewswire Inc.GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesNASDAQ:GENEGenetic Technologies Ltd
04/22/20243:00PMGlobeNewswire Inc.Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
04/18/202412:17PMGlobeNewswire Inc.Genetic Technologies Announces $2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
04/17/20248:00AMGlobeNewswire Inc.New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesNASDAQ:GENEGenetic Technologies Ltd
04/16/20248:00AMGlobeNewswire Inc.GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearNASDAQ:GENEGenetic Technologies Ltd
04/11/20248:00AMGlobeNewswire Inc.GTG to pilot GeneType in Breast Screen centers across the U.S.NASDAQ:GENEGenetic Technologies Ltd
04/08/20248:00AMGlobeNewswire Inc.EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”NASDAQ:GENEGenetic Technologies Ltd
04/02/20248:05AMGlobeNewswire Inc.Genetic Technologies’ Digital Strategy Ignites Significant Traction in US MarketNASDAQ:GENEGenetic Technologies Ltd
03/26/20248:00AMGlobeNewswire Inc.GTG Global Collaborations and Innovation UpdateNASDAQ:GENEGenetic Technologies Ltd
03/25/20248:00AMGlobeNewswire Inc.GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised HealthcareNASDAQ:GENEGenetic Technologies Ltd
02/26/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
02/15/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
02/14/20242:14PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GENEGenetic Technologies Ltd
01/31/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
01/31/20248:00AMGlobeNewswire Inc.Launching our most comprehensive test and expanding into new global marketsNASDAQ:GENEGenetic Technologies Ltd
01/09/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
01/05/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
01/05/20248:00AMGlobeNewswire Inc.Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:GENEGenetic Technologies Ltd
01/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
12/28/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
12/27/20238:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
12/20/20235:00PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:GENEGenetic Technologies Ltd
12/14/20238:00AMGlobeNewswire Inc.GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized WellnessNASDAQ:GENEGenetic Technologies Ltd
12/12/20238:00AMGlobeNewswire Inc.Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio ChangeNASDAQ:GENEGenetic Technologies Ltd
10/30/20238:00AMGlobeNewswire Inc.Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical TrialNASDAQ:GENEGenetic Technologies Ltd
10/18/20238:30AMGlobeNewswire Inc.GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and TreatmentNASDAQ:GENEGenetic Technologies Ltd
09/27/20239:00AMGlobeNewswire Inc.GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital NetworkNASDAQ:GENEGenetic Technologies Ltd
09/12/20238:00AMGlobeNewswire Inc.Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian ReleaseNASDAQ:GENEGenetic Technologies Ltd
 Showing the most relevant articles for your search:NASDAQ:GENE

Your Recent History

Delayed Upgrade Clock